StockWatch
·

NGL FINE-CHEM LTD.

BSE: 524774

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
158.66
+10.1%+33.1%
Expenditure
140.62
+15.0%+29.5%
Net Profit
12.84
-22.0%+62.6%
OPM %
15.00%
+0.53pp+3.30pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-19.6229.7279.07128.42177.76Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

NGL Fine-Chem Q1 FY27: PAT nearly doubles YoY to ₹18.4 Cr, margins expand to 16.7%

pharma intermediates · margin expansion · opm expansion

ResultsQ1 FY2712 Aug 20263 minPharma & Healthcare
Latest

Corporate Events

Board MeetingNGLFINE
2026
6Nov

Board Meeting

To consider and approve the Unaudited Standalone and Consoli…

BSE Filing ↗
Board MeetingNGLFINE
2026
25Aug

Board Meeting

The 45th Annual General Meeting (AGM) of NGL Fine-Chem Limit…

BSE Filing ↗
DividendNGLFINE
2026
18Aug

₹1.75 / share

BSE Filing ↗
Board MeetingNGLFINE
2026
12Aug

Board Meeting

The Board of Directors considered and approved the Unaudited…

BSE Filing ↗
Board MeetingNGLFINE
2026
21May

Board Meeting

The board meeting is scheduled to consider and approve Audit…

BSE Filing ↗
Board MeetingNGLFINE
2026
3Feb

Board Meeting

approve the unaudited Standalone & Consolidated Financial Re…

BSE Filing ↗
Board MeetingNGLFINE
2025
1Aug

Board Meeting

approve the unaudited Standalone & Consolidated Financial Re…

BSE Filing ↗
Board MeetingNGLFINE
2025
22May

Board Meeting

Approve the Standalone & Consolidated Audited Balance Sheet,…

BSE Filing ↗
Board MeetingNGLFINE
2025
7Feb

Board Meeting

approve the unaudited Standalone & Consolidated Financial Re…

BSE Filing ↗
Board MeetingNGLFINE
2024
8Nov

Board Meeting

Approve unaudited Standalone & Consolidated Financial Result…

BSE Filing ↗
DividendNGLFINE
2024
16Aug

₹1.75 / share

BSE Filing ↗
Board MeetingNGLFINE
2024
12Aug

Board Meeting

approve the unaudited Standalone & Consolidated Financial Re…

BSE Filing ↗
Board MeetingNGLFINE
2024
18Mar

Board Meeting

Consider and approve appointment of Mr. Dhananjay Mungale as…

BSE Filing ↗
Board MeetingNGLFINE
2024
12Feb

Board Meeting

Approval of Unaudited Financial Results for Q3 and 9 months …

BSE Filing ↗
Board MeetingNGLFINE
2023
10Nov

Board Meeting

Approval of Unaudited Financial Results for the quarter ende…

BSE Filing ↗
DividendNGLFINE
2023
14Jul

₹2 / share

BSE Filing ↗